These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 17097377
1. Rituximab for the treatment of the skin manifestations of dermatomyositis: a report of 3 cases. Dinh HV, McCormack C, Hall S, Prince HM. J Am Acad Dermatol; 2007 Jan; 56(1):148-53. PubMed ID: 17097377 [Abstract] [Full Text] [Related]
2. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab). Morrison LH. J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367 [Abstract] [Full Text] [Related]
3. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Arin MJ, Engert A, Krieg T, Hunzelmann N. Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153 [Abstract] [Full Text] [Related]
9. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Ocul Immunol Inflamm; 2007 May; 15(2):99-104. PubMed ID: 17558834 [Abstract] [Full Text] [Related]
10. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ. Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414 [Abstract] [Full Text] [Related]
11. A case of refractory vasculitic ulcers in a systemic lupus erythematosus patient responding to rituximab and hyperbaric oxygen therapy. Lui NL, Thumboo J, Fong KY. Int J Rheum Dis; 2009 Dec; 12(4):366-9. PubMed ID: 20374378 [Abstract] [Full Text] [Related]